Significant class action cases involving different types of FDA-regulated products have been prevalent in the past several years. This webinar will discuss recent trends in class action litigation, including jurisdictions in which actions are most frequently filed, common claims theories, and settlement strategies. Speakers will also discuss how recent amendments to Rule 23 of the Federal Rules of Civil Procedure could affect litigation strategy, the evolving standard of ascertainability in addressing class certification, and damages models. Finally, we will look at the future of class actions for FDA-regulated products.
- +$100 for nonmembers
On-demand webinar recordings are sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day of your purchase.